944 Index
Stimulant use disorder (continued)
culture-related diagnostic issues in, 565
development and course of, 564–565
diagnostic criteria for, 561–562
diagnostic features of, 563
diagnostic markers for, 565–566
differential diagnosis of, 566
functional consequences of, 566
prevalence of, 564
risk and prognostic factors for, 565
specifiers for, 563
Stimulant withdrawal, 484, 569–570
associated features supporting diagnosis of, 570
diagnostic criteria for, 569
differential diagnosis of, 570
Stroke, 46, 73, 117
bipolar disorder and, 146, 147
depressive disorders and, 164, 167, 181–182
Stuttering. See Childhood-onset fluency disorder 
(stuttering)
Substance-induced disorders, 481, 485–490. See 
also specific substances of abuse
alcohol-related, 497–503
caffeine-related, 503–508
cannabis-related, 516–519
hallucinogen-related, 527–533
inhalant-related, 538–540
opioid-related, 546–549
other (or unknown) substance–related, 581–585
sedative-, hypnotic-, or anxiolytic-related, 
556–560
substance intoxication and withdrawal, 481, 
485–487 ( See also  Intoxication; 
Withdrawal from substance)
associated with use of multiple substances, 
486
development and course of, 487
duration of effects and, 486
laboratory findings associated with, 
486–487
recording procedures for, 487
related to route of administration and